DocGo Inc. (NASDAQ:DCGO) Shares Purchased by Barclays PLC

Barclays PLC increased its position in shares of DocGo Inc. (NASDAQ:DCGO) by 279.7% in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 134,923 shares of the company’s stock after purchasing an additional 99,387 shares during the period. Barclays PLC owned 0.13% of DocGo worth $447,000 at the end of the most recent quarter.

A number of other institutional investors also recently bought and sold shares of DCGO. Marathon Capital Management lifted its stake in shares of DocGo by 2.3% in the 2nd quarter. Marathon Capital Management now owns 277,100 shares of the company’s stock valued at $856,000 after purchasing an additional 6,285 shares during the last quarter. The Manufacturers Life Insurance Company lifted its position in DocGo by 31.6% in the second quarter. The Manufacturers Life Insurance Company now owns 40,401 shares of the company’s stock valued at $125,000 after buying an additional 9,696 shares during the last quarter. Centiva Capital LP purchased a new position in DocGo during the third quarter worth about $43,000. Victory Capital Management Inc. increased its position in shares of DocGo by 124.0% during the second quarter. Victory Capital Management Inc. now owns 25,635 shares of the company’s stock valued at $79,000 after acquiring an additional 14,191 shares during the last quarter. Finally, WCM Investment Management LLC raised its stake in shares of DocGo by 0.6% in the 3rd quarter. WCM Investment Management LLC now owns 2,626,971 shares of the company’s stock valued at $8,879,000 after acquiring an additional 15,933 shares during the period. 56.44% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

Separately, Needham & Company LLC reaffirmed a “buy” rating and set a $7.00 price objective on shares of DocGo in a research report on Thursday. Five investment analysts have rated the stock with a buy rating, According to data from MarketBeat, the company has an average rating of “Buy” and an average target price of $6.10.

DocGo Price Performance

NASDAQ DCGO opened at $4.17 on Friday. The company has a market cap of $425.55 million, a P/E ratio of 14.89, a P/E/G ratio of 11.49 and a beta of 0.97. The stock has a 50-day moving average of $4.23 and a two-hundred day moving average of $3.69. DocGo Inc. has a 1-year low of $2.75 and a 1-year high of $4.86.

Insider Activity

In related news, General Counsel Ely D. Tendler sold 23,088 shares of the company’s stock in a transaction that occurred on Monday, December 16th. The shares were sold at an average price of $4.44, for a total transaction of $102,510.72. Following the sale, the general counsel now directly owns 175,645 shares of the company’s stock, valued at $779,863.80. This represents a 11.62 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Insiders own 2.70% of the company’s stock.

DocGo Profile

DocGo Inc provides mobile health and medical transportation services for various health care providers in the United States and the United Kingdom. The company's transportation services include emergency response services; and non-emergency transport services comprise ambulance and wheelchair transportation services.